Literature DB >> 21993980

Comparison of 1.5 and 3.0 T for contrast-enhanced pulmonary magnetic resonance angiography.

Frank Joseph Londy1, Suzan Lowe, Paul D Stein, John G Weg, Robert L Eisner, Kenneth V Leeper, Pamela K Woodard, H Dirk Sostman, Kathleen A Jablonski, Sarah E Fowler, Charles A Hales, Russell D Hull, Alexander Gottschalk, David P Naidich, Thomas L Chenevert.   

Abstract

OBJECTIVE: In a recent multi-center trial of gadolinium contrast-enhanced magnetic resonance angiography (Gd-MRA) for diagnosis of acute pulmonary embolism (PE), two centers utilized a common MRI platform though at different field strengths (1.5T and 3T) and realized a signal-to-noise gain with the 3T platform. This retrospective analysis investigates this gain in signal-to-noise of pulmonary vascular targets.
METHODS: Thirty consecutive pulmonary MRA examinations acquired on a 1.5T system at one institution were compared to 30 consecutive pulmonary MRA examinations acquired on a 3T system at a different institution. Both systems were from the same MRI manufacturer and both used the same Gd-MRA pulse sequence, although there were some protocol adjustments made due to field strength differences. Region-of-interests were manually defined on the main pulmonary artery, 4 pulmonary veins, thoracic aorta, and background lung for objective measurement of signal-to-noise, contrast-to-noise, and bolus timing bias between centers.
RESULTS: The 3T pulmonary MRA protocol achieved higher spatial resolution yet maintained significantly higher signal-to-noise ratio (≥13%, p = 0.03) in the main pulmonary vessels relative to 1.5T. There was no evidence of operator bias in bolus timing or patient hemodynamic differences between groups.
CONCLUSION: Relative to 1.5T, higher spatial resolution Gd-MRA can be achieved at 3T with a sustained or greater signal-to-noise ratio of enhanced vasculature.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21993980      PMCID: PMC3698487          DOI: 10.1177/1076029611419840

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  24 in total

1.  Effect of field strength on susceptibility artifacts in magnetic resonance imaging.

Authors:  K Farahani; U Sinha; S Sinha; L C Chiu; R B Lufkin
Journal:  Comput Med Imaging Graph       Date:  1990 Nov-Dec       Impact factor: 4.790

2.  Contrast-enhanced MRA in pre-embolization assessment of a pulmonary arteriovenous malformation.

Authors:  T G Vrachliotis; K G Bis; M J Kirsch; A N Shetty
Journal:  J Magn Reson Imaging       Date:  1997 Mar-Apr       Impact factor: 4.813

3.  Accuracy of contrast-enhanced magnetic resonance angiography in chronic thromboembolic disease.

Authors:  K Wolff; C J Bergin; M A King; E Ghadishah; D W Sung; P Clopton; J J Bookstein; W R Auger; K M Moser
Journal:  Acad Radiol       Date:  1996-01       Impact factor: 3.173

4.  Pulmonary angiography with MR imaging: preliminary clinical experience.

Authors:  T M Grist; H D Sostman; J R MacFall; T K Foo; C E Spritzer; L Witty; G E Newman; J F Debatin; V Tapson; H A Saltzman
Journal:  Radiology       Date:  1993-11       Impact factor: 11.105

5.  Clinical evaluation of pulmonary 3D time-of-flight MRA with breath holding using contrast media.

Authors:  H Isoda; T Ushimi; T Masui; T Mochizuki; S Goto; K Suzuki; T Shirakawa; A Ohta; M Takahashi; M Kaneko
Journal:  J Comput Assist Tomogr       Date:  1995 Nov-Dec       Impact factor: 1.826

6.  Pulmonary vascular cine MR imaging: a noninvasive approach to dynamic imaging of the pulmonary circulation.

Authors:  W B Gefter; H Hatabu; B J Dinsmore; L Axel; H I Palevsky; N Reichek; M L Schiebler; H Y Kressel
Journal:  Radiology       Date:  1990-09       Impact factor: 11.105

7.  Chronic thromboembolism: diagnosis with helical CT and MR imaging with angiographic and surgical correlation.

Authors:  C J Bergin; C B Sirlin; J P Hauschildt; T V Huynh; W R Auger; P F Fedullo; D P Kapelanski
Journal:  Radiology       Date:  1997-09       Impact factor: 11.105

8.  Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED).

Authors: 
Journal:  JAMA       Date:  1990 May 23-30       Impact factor: 56.272

9.  Pulmonary embolism: comparison of MR images with radionuclide and angiographic studies.

Authors:  W A Erdman; R M Peshock; H C Redman; F Bonte; M Meyerson; H T Jayson; G L Miller; G D Clarke; R W Parkey
Journal:  Radiology       Date:  1994-02       Impact factor: 11.105

10.  Suspected pulmonary embolism: prospective evaluation with pulmonary MR angiography.

Authors:  M L Schiebler; G A Holland; H Hatabu; J Listerud; T Foo; H Palevsky; H Edmunds; W B Gefter
Journal:  Radiology       Date:  1993-10       Impact factor: 11.105

View more
  6 in total

Review 1.  Contrast-enhanced pulmonary MRA for the primary diagnosis of pulmonary embolism: current state of the art and future directions.

Authors:  Donald G Benson; Mark L Schiebler; Michael D Repplinger; Christopher J François; Thomas M Grist; Scott B Reeder; Scott K Nagle
Journal:  Br J Radiol       Date:  2017-04-12       Impact factor: 3.039

2.  Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Huyen T Nguyen; Kamal S Pohar; Guang Jia; Zarine K Shah; Amir Mortazavi; Debra L Zynger; Lai Wei; Daniel Clark; Xiangyu Yang; Michael V Knopp
Journal:  Invest Radiol       Date:  2014-06       Impact factor: 6.016

3.  Pulmonary MRA: differentiation of pulmonary embolism from truncation artefact.

Authors:  Peter Bannas; Mark L Schiebler; Utaroh Motosugi; Christopher J François; Scott B Reeder; Scott K Nagle
Journal:  Eur Radiol       Date:  2014-05-28       Impact factor: 5.315

4.  Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters.

Authors:  Huyen T Nguyen; Guang Jia; Zarine K Shah; Kamal Pohar; Amir Mortazavi; Debra L Zynger; Lai Wei; Xiangyu Yang; Daniel Clark; Michael V Knopp
Journal:  J Magn Reson Imaging       Date:  2014-06-19       Impact factor: 4.813

5.  Magnetic resonance angiography using fresh blood imaging in oral and maxillofacial regions.

Authors:  Masafumi Oda; Tatsurou Tanaka; Shinji Kito; Manabu Habu; Masaaki Kodama; Shinya Kokuryo; Ikuya Miyamoto; Daigo Yoshiga; Kensuke Yamauchi; Shinnosuke Nogami; Nao Wakasugi-Sato; Shinobu Matsumoto-Takeda; Ayataka Ishikawa; Ikuko Nishida; Katsura Saeki; Kazumasa Morikawa; Kou Matsuo; Yuji Seta; Yoshihiro Yamashita; Kenshi Maki; Kazuhiro Tominaga; Yasuhiro Morimoto
Journal:  Int J Dent       Date:  2012-10-17

6.  The presurgical T staging of non-small cell lung cancer: efficacy comparison of 64-MDCT and 3.0 T MRI.

Authors:  Wei Tang; Ning Wu; Han OuYang; Yao Huang; Li Liu; Meng Li
Journal:  Cancer Imaging       Date:  2015-09-03       Impact factor: 3.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.